Investors / Verge HealthTech Fund
Verge HealthTech Fund
Verge HealthTech Fund is a venture capital firm based in Singapore. Verge HealthTech Fund has backed 2 Canadian AI companies in the Index, joining 2 tracked rounds. The most recent was RetiSpec's US$10M Series A in July 2024. Verge HealthTech Fund most often invests alongside Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Amplify Capital and BoxOne Ventures.
VC based in Singapore. 2 Canadian AI companies in the Index, 2 tracked rounds.
- Type
- VC
- HQ country
- Singapore
- Companies
- 2
- Tracked rounds
- 2
- Led
- 0
- First tracked deal
- Pathway Medical, Nov 2023
- Latest tracked deal
- RetiSpec, Jul 2024
Portfolio
| Company | Rounds joined (date, round size) | Company's total raised | Role |
|---|---|---|---|
| RetiSpec | Series A · Jul 2024 · US$10M round | US$10M | — |
| Pathway Medical | Seed · Nov 2023 · C$5M round | C$5M | — |
A round's size is the whole round as announced, not this investor's cheque.
Frequent co-investors
Alzheimer's Drug Discovery Foundation Diagnostics Accelerator (1 shared round), Amplify Capital (1 shared round), BoxOne Ventures (1 shared round), Centre for Aging + Brain Health Innovation (1 shared round), Discovery Capital (University of Minnesota) (1 shared round), Eli Lilly and Company (1 shared round), Formentera Capital (1 shared round), Gentex Corporation (1 shared round)
Data as of November 10, 2026.